Added to YB: 2024-04-04
Pitch date: 2024-04-02
MREO [bullish]
Mereo BioPharma Group plc
-35.21%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
Market Cap
$281.6M
Pitch Price
$3.38
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.22
P/E
-5.60
EV/Sales
452.15
Sector
Biotechnology
Category
special_situation
Raging Bull Investments' Largest Winners from Q1: Mereo BioPharma Group plc
MREO: Pre-rev biotech. Setrusumab Phase 3 trial derisked. Alvelestat for AATD frustrates - no partnership yet despite Sanofi's $1.7B INBRX deal. Concern over value, but activist Rubric (4 board seats) comforts. At $3, not paying much for alvelestat. Author up 300% in 19 months, holding.
Read full article (2 min)